Evidence map›Paper›PMID 21187948›Full record

ArticleInternational journal of nanomedicine2010

L-tyrosine-loaded nanoparticles increase the antitumoral activity of direct electric current in a metastatic melanoma cell model.

Vânia Emerich Bucco de Campos, Cesar Augusto Antunes Teixeira, Venicio Feo da Veiga, Eduardo Ricci, Carla Holandino

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Frontiers in pharmacology · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Antitumor effects of electrochemical treatment.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vânia Emerich Bucco de CamposDepartamento de Medicamentos, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Cesar Augusto Antunes Teixeira
Venicio Feo da Veiga
Eduardo Ricci
Carla Holandino

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibition of tumor growth induced by treatment with direct electric current (DC) has been reported in several models. One of the mechanisms responsible for the antitumoral activity of DC is the generation of oxidative species, known as chloramines. With the aim of increasing chloramine production in the electrolytic medium and optimizing the antitumoral effects of DC, poly(ɛ-caprolactone) (PCL) nanoparticles (NPs) loaded with the amino acid tyrosine were obtained. The physical-chemical characterization showed that the NPs presented size in nanometric range and monomodal distribution. A slightly negative electrokinetic potential was also found in both blank NPs and L-tyrosine-loaded PCL NPs. The yield of the loading process was approximately 50%. Within 3 h of dissolution assay, a burst release of about 80% L-tyrosine was obtained. The in vitro cytotoxicity of DC was significantly increased when associated with L-tyrosine-loaded NPs, using a murine multidrug-resistant melanoma cell line model. This study showed that the use of the combination of nanotechnology and DC has a promising antineoplastic potential and opens a new perspective in cancer therapy.

Indexed as

AnimalsAntineoplastic AgentsCell Line, TumorCell ProliferationCell SurvivalCombined Modality TherapyElectric Stimulation TherapyElectrochemical TechniquesMelanoma, ExperimentalMiceMicroscopy, Electron, TransmissionNanoparticlesParticle SizePolyestersTrypan BlueTyrosineAntineoplastic AgentspolycaprolactonePolyestersTrypan BlueTyrosineB16F10 cellscancer therapydirect electric currentl-tyrosinenanotechnology

Identifiers

PMID21187948
PMCPMC3010158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.